Skip to main content

HLN · Haleon plc · Webcasts, Transcripts & Audio

Track HLN — free
$9.02 -0.07 (-0.72%) Play latest call Q3 2026 earnings call transcript
Market Cap
$39.50B
Shares
4.38B
Volume · Nov 19 4.5M Avg daily vol (3M) 18.85M

Haleon plc Webcasts

Earnings calls, investor updates, investor days and conferences for Haleon plc (HLN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-10-29
Haleon plc (HLN) Q3 2026 Earnings Call Transcript
Balanced tone Q3 performance shortfall North America commercial execution European market conditions
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-07-30
Haleon plc (HLN) Q2 2026 Earnings Call Transcript
Confident tone Emerging markets growth engine win-is-won strategy and medium-term guidance North America execution and recovery
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
Haleon plc (HLN) Q1 2026 Earnings Call Transcript
Positive tone Cold and Flu / Respiratory E-commerce / China Middle East / Geopolitical Risk
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Haleon plc (HLN) Q4 2025 Earnings Call Transcript
Positive tone Emerging markets performance (India, China, LatAm, EMEA) Oral Health category strength and shelf resets A&P investment and innovation
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Haleon plc (HLN) Q3 2025 Earnings Call Transcript
Positive tone North America softness and outlook Emerging markets (India, LatAm, APAC) Oral Health and Sensodyne
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Date not confirmed
Haleon plc (HLN) Q2 2025 Earnings Call Transcript
Balanced tone Oral Health and Digestive Health Strength Emerging Markets Growth Advil and Centrum Recovery
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Haleon plc (HLN) Q1 2025 Earnings Call Transcript
Positive tone Emerging markets performance Innovation and product launches Organic revenue growth and guidance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Date not confirmed
Haleon plc (HLN) Q4 2024 Earnings Call Transcript
Positive tone Oral Health and Innovation 2025 Guidance and Quarterly Phasing Emerging Markets: India and China
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Haleon plc (HLN) Q2 2024 Earnings Call Transcript
Confident tone Eroxon launch and product innovation Category dynamics (Pain Relief, Respi, Oral Health, VMS) Margin and A&P investment in H2
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Haleon plc (HLN) Q1 2024 Earnings Call Transcript
Positive tone U.S. volume softness and retailer inventory adjustments Pain relief and respiratory comparatives Organic revenue growth and full-year guidance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Haleon plc (HLN) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Haleon plc (HLN) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–12 of 12 webcasts
Key facts CIK 1900304 CUSIP 405552100 13F (30d) 632 filings 565 filers Visit website Investor relations